drugset / Trial / NCT07118215
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of KarXT administration on the drug levels of midazolam, fexofenadine, and digoxin in healthy adult participants.
Timeline
- Start
- 2025-09-29
- Primary completion
- 2026-06-25
- Completion
- 2026-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | Fexofenadine | Unknown | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Background | Trospium | Small molecule | — | — |
| Background | Xanomeline | Small molecule | — | — |
Indications
No indication recorded.